SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (309)10/28/2001 11:49:55 PM
From: scaram(o)uche  Read Replies (1) of 724
 
MZ:

They should be highly profitable at the next quarter, and profit should be the norm for the foreseeable future, IMO.

See the post here..........

Message 16485073

by Extra Pale. There were restructuring charges for the last quarter, and NBSC has carried the R&D expense at DGI Biotechnologies for years. NBSC now owns only 47% of DGI, and no longer will carry that R&D expense.

Sales growth rate? I am focused on current value, but that is of course a good question. 20% sounds good. After extensive research for the past 20 seconds, 20% sounds good. I believe that orders are about to go through the roof, but increasing capacity to meet demand seems to have been a weakness in the past.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext